TAVI registry for people with severe aortic valve disease
Part of Heart & circulation clinical trials.
This registry follows people with severe aortic valve narrowing (and sometimes a worn-out valve) who are considered good candidates for TAVI, a valve-replacement procedure. It helps doctors better understand outcomes and care over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have symptoms from severe aortic stenosis, or your earlier bioprosthetic valve is failing
- A Heart Team has said you are a good candidate for TAVI (through their evaluation)
- You can sign consent to join the study
- You do not have reasons that make TAVI unsafe, like infection (endocarditis) or a clot/mass in the heart
- You can attend planned follow-up visits and understand the study instructions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry is for people with severe, symptomatic aortic valve narrowing who are planning a TAVI procedure (a less invasive valve replacement). It aims to better track and improve how patients do after the valve is replaced, based on how the procedure is planned and performed.
This trial tests if a heart valve replacement procedure called TAVI can be safely done at heart centers that do not have a full heart surgery team available onsite. It is for people with severe narrowing of the aortic valve who are already planned for TAVI through the leg artery.
This is a patient registry that collects information from people who receive TAVI, a procedure used to treat certain heart valve problems. It may help doctors better understand who benefits and how patients do over time.
This study tracks patients with severe aortic stenosis who receive the Myval transcatheter heart valve during TAVR (a less-invasive valve replacement). It aims to understand how well the valve works over time.
This study is a real-world registry that collects information from people who receive TAVI, a procedure to treat a damaged heart valve. It may help doctors understand outcomes and improve care, even though it isn’t testing a new drug.
This is a registry study that tracks how people do after a TAVR procedure for a severely narrowed aortic heart valve. It helps doctors learn more about long-term outcomes and improve care for future patients.
Hear when a new Aortic Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.